T. Rowe Price Associates’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $886K | Sell |
35,583
-515
| -1% | -$12.8K | ﹤0.01% | 2039 |
|
|
2025
Q1 | $1.12M | Buy |
36,098
+3,143
| +10% | +$97.5K | ﹤0.01% | 1896 |
|
|
2024
Q4 | $1.04M | Sell |
32,955
-706
| -2% | -$22.3K | ﹤0.01% | 1939 |
|
|
2024
Q3 | $1.95M | Buy |
33,661
+986
| +3% | +$57.1K | ﹤0.01% | 1648 |
|
|
2024
Q2 | $1.33M | Buy |
32,675
+1,305
| +4% | +$53K | ﹤0.01% | 1765 |
|
|
2024
Q1 | $1.32M | Buy |
31,370
+1,587
| +5% | +$66.7K | ﹤0.01% | 1768 |
|
|
2023
Q4 | $1.14M | Buy |
29,783
+1,086
| +4% | +$41.6K | ﹤0.01% | 1802 |
|
|
2023
Q3 | $886K | Buy |
28,697
+1,720
| +6% | +$53.1K | ﹤0.01% | 1850 |
|
|
2023
Q2 | $853K | Buy |
26,977
+1,182
| +5% | +$37.4K | ﹤0.01% | 1879 |
|
|
2023
Q1 | $941K | Buy |
25,795
+968
| +4% | +$35.3K | ﹤0.01% | 1819 |
|
|
2022
Q4 | $735K | Buy |
24,827
+3,248
| +15% | +$96.2K | ﹤0.01% | 1944 |
|
|
2022
Q3 | $842K | Buy |
21,579
+3,731
| +21% | +$146K | ﹤0.01% | 1842 |
|
|
2022
Q2 | $689K | Sell |
17,848
-438
| -2% | -$16.9K | ﹤0.01% | 2068 |
|
|
2022
Q1 | $886K | Buy |
18,286
+3,166
| +21% | +$153K | ﹤0.01% | 2055 |
|
|
2021
Q4 | $1.11M | Buy |
15,120
+1,888
| +14% | +$139K | ﹤0.01% | 1980 |
|
|
2021
Q3 | $1.21M | Buy |
+13,232
| New | +$1.21M | ﹤0.01% | 1955 |
|